4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-021846
President and CEO sold 5,475 shares at an average $0.49 ($2,710)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-31 | Sale : show line 1 in the form 10b5-1 | −2,676 | $0.50 | $1,338 | 675,407 | D |
| 2023-08-01 | Sale : show line 2 in the form 10b5-1 | −2,799 | $0.49 | $1,372 | 672,608 | D |
| Open-market sales · 5,475 sh · avg $0.49 · $2,710 | ||||||
Loading xslF345X05/form4.xml…